Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Neurophth Announces First Patient Dosed in Phase I/II Clinical Trial of Second Gene Therapy 2023-08-17 21:00
Minghui Pharmaceutical Inc. Announces First Patient Enrollment in the Phase 3 Clinical Study of MH004 Cream for Treatment of Mild to Moderate Atopic Dermatitis 2023-08-17 19:00
I-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updates 2023-08-17 18:00
2023WCLC Oral Presentation | Molecular Analysis Validates the Effectiveness of Tumor Tissue-Based and Plasma ctDNA Testing in Identifying NSCLC Patients with EGFR Exon20ins Eligible for Treatment with Sunvozertinib 2023-08-17 17:10
Innovent Announces the NMPA Approval of SINTBILO® (Tafolecimab Injection) for the Treatment of Adult Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia 2023-08-17 08:00
Nippon Express (Ireland) Opens New Warehouse in Dublin, Beginning Operations July 1 2023-08-16 14:00
Nippon Express (Ireland) Opens New Warehouse in Dublin, Beginning Operations July 1 2023-08-16 14:00
Daewoong Pharmaceutical Initiates Global Export of 'Novel Drug' Launching 'Fexuprazan' in the Philippines 2023-08-16 13:00
Charmacy Pharmaceutical Has Obtained the Provincial Capital Support 2023-08-16 09:00
MedAlliance announces the completion of enrollment in SAVE Trial with SELUTION SLR for Treatment of AV Fistulas in Renal Dialysis Patients 2023-08-16 08:00
Transcenta to Present Three Study Results at ESMO 2023 2023-08-16 08:00
Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis 2023-08-15 22:50
CStone Pharmaceuticals Reports 2023 Interim Results and Updates 2023-08-15 22:33
Everest Medicines' Partner Venatorx Receives FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI) 2023-08-15 20:19
OnCusp Therapeutics Receives FDA Clearance for the Phase 1 Clinical Trial of CUSP06, Targeting Ovarian Cancer and Other Advanced Solid Tumors 2023-08-15 20:00
TB Alliance Announces Partnership with Remington Pharmaceuticals to Commercialize New Therapy for Drug-Resistant Forms of TB in Pakistan 2023-08-14 21:30
Kelun-Biotech announces that a Phase III clinical trial of core product SKB264 (MK-2870, TROP2-ADC) in patients with unresectable locally advanced, recurrent or metastatic TNBC who have failed second-line or above prior standard of care has met its primary endpoint 2023-08-14 12:50
Streamlining Generic Drug Immunogenicity Evaluation: EpiVax's "PANDA" Approach 2023-08-11 21:14
Asieris Announces Positive Phase III Bridging Trial of Hexvix®, a Diagnostic Drug for Bladder Cancer 2023-08-11 17:00
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients 2023-08-11 11:14
1 48 49 50 51 52 375